Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?

Virginia G. Kaklamani, William J. Gradishar

Research output: Contribution to journalReview articlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology